DK1019426T3 - Hidtil ukendte A1-adenosinreceptoragonister og -antagonister - Google Patents

Hidtil ukendte A1-adenosinreceptoragonister og -antagonister

Info

Publication number: DK1019426T3
Authority: DK; Denmark
Prior art keywords: antagonists; novel; receptor agonists; adenosine receptor; adenosine
Prior art date: 1995-12-29

Application number

DK96945316T

Other languages

English (en)

Inventor

Luiz Belardinelli

Ray Olsson

Stephen Baker

Peter J Scammells

Peter G Milner

Jurg R Pfister

Original Assignee

Univ Florida

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-12-29

Filing date

1996-12-26

Publication date

2003-07-14

1996-12-26 Application filed by Univ Florida filed Critical Univ Florida

2003-07-14 Application granted granted Critical

2003-07-14 Publication of DK1019426T3 publication Critical patent/DK1019426T3/da

Links

101150007969 ADORA1 gene Proteins 0.000 title 1
239000003379 purinergic P1 receptor agonist Substances 0.000 title 1
239000000296 purinergic P1 receptor antagonist Substances 0.000 title 1
LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 abstract 2
OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 abstract 2
239000000203 mixture Substances 0.000 abstract 2
102000009346 Adenosine receptors Human genes 0.000 abstract 1
108050000203 Adenosine receptors Proteins 0.000 abstract 1
239000002126 C01EB10 - Adenosine Substances 0.000 abstract 1
229960005305 adenosine Drugs 0.000 abstract 1
239000000556 agonist Substances 0.000 abstract 1
206010003119 arrhythmia Diseases 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
230000003389 potentiating effect Effects 0.000 abstract 1
229940075420 xanthine Drugs 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicinal Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)

DK96945316T 1995-12-29 1996-12-26 Hidtil ukendte A1-adenosinreceptoragonister og -antagonister DK1019426T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/581,655 US5736528A (en)	1993-10-28	1995-12-29	N6 -(epoxynorborn-2-yl) adenosines as A1 adenosine receptor agonists
PCT/US1996/020840 WO1997024363A1 (en)	1995-12-29	1996-12-26	Novel a1 adenosine receptor agonists and antagonists

Publications (1)

Publication Number	Publication Date
DK1019426T3 true DK1019426T3 (da)	2003-07-14

Family

ID=24326044

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK96945316T DK1019426T3 (da)	1995-12-29	1996-12-26	Hidtil ukendte A1-adenosinreceptoragonister og -antagonister

Country Status (15)

Country	Link
US (2)	US5736528A (da)
EP (1)	EP1019426B1 (da)
JP (1)	JP2000502712A (da)
KR (1)	KR19990076916A (da)
CN (1)	CN1163502C (da)
AT (1)	ATE234322T1 (da)
AU (1)	AU728439B2 (da)
BR (1)	BR9612324A (da)
CA (1)	CA2238736C (da)
DE (1)	DE69626705T2 (da)
DK (1)	DK1019426T3 (da)
ES (1)	ES2190487T3 (da)
NZ (1)	NZ326608A (da)
PT (1)	PT1019426E (da)
WO (1)	WO1997024363A1 (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5736528A (en) *	1993-10-28	1998-04-07	University Of Florida Research Foundation, Inc.	N6 -(epoxynorborn-2-yl) adenosines as A1 adenosine receptor agonists
US5789416B1 (en) *	1996-08-27	1999-10-05	Cv Therapeutics Inc	N6 mono heterocyclic substituted adenosine derivatives
IL127947A0 (en) *	1999-01-07	1999-11-30	Can Fite Technologies Ltd	Pharmaceutical use of adenosine agonists
US6790839B2 (en)	1999-01-07	2004-09-14	Can-Fite Biopharma Ltd.	Pharmaceutical administration of adenosine agonists
US6576620B2 (en) *	1999-12-03	2003-06-10	Cv Therapeutics, Inc.	Method of identifying partial adenosine A1 receptor agonists
US20030008841A1 (en) *	2000-08-30	2003-01-09	Rene Devos	Anti-HCV nucleoside derivatives
US6537974B2 (en) *	2000-09-08	2003-03-25	Cv Therapeutics, Inc.	Method of treating arrhythmias
RU2248208C2 (ru) *	2000-09-08	2005-03-20	Си Ви Терапьютикс, Инк.	Пуринрибозиды в качестве антиаритмических средств
CA2347879A1 (en)	2001-05-11	2002-11-11	Vanderbilt University	Substituted dicinnamoylquinides and their use in augmentation of adenosine function
ATE418991T1 (de) *	2002-04-18	2009-01-15	Cv Therapeutics Inc	Methode zur behandlung von herzrhythmusstörungen mit einem a1 adenosin agonist zusammen mit einem beta blocker
US20040121406A1 (en) *	2002-05-23	2004-06-24	Wilson Constance Neely	Methods and formulations for increasing the affinity of a1 adenosine receptor ligands for the a1 adenosine receptor
EA200500005A1 (ru) *	2002-06-12	2005-06-30	Байоджен Айдек Ма Инк.	Способ лечения повреждения, вызванного реперфузией после ишемии, с использованием антагонистов рецептора аденозина
US20040229901A1 (en) *	2003-02-24	2004-11-18	Lauren Otsuki	Method of treatment of disease using an adenosine A1 receptor antagonist
EP1932529A1 (en)	2003-04-25	2008-06-18	Novacardia, Inc.	Method of improved diuresis in individuals with impaired renal function
MXPA05011371A (es) *	2003-04-25	2005-12-01	Novacardia Inc	Metodo para mejorar la diuresis en individuos con la funcion renal deteriorada.
US20060293312A1 (en) *	2003-04-25	2006-12-28	Howard Dittrich	Method of improved diuresis in individuals with impaired renal function
BRPI0509753A (pt) *	2004-04-16	2007-10-16	Novacardia Inc	composição farmacêutica e método de tratamento de doença cardiovascular
EP1809374A4 (en) *	2004-10-12	2008-09-10	Closed Loop Therapies Ltd	IMPLANTABLE METHODS AND DEVICES FOR TREATING SUPRAVENTRICULAR ARRHYTHMIAS
ES2273599B1 (es) *	2005-10-14	2008-06-01	Universidad De Barcelona	Compuestos para el tratamiento de la fibrilacion auricular.
CN101466383A (zh) *	2006-06-16	2009-06-24	美国诺华卡迪亚公司	包含低频率投与aa1ra的肾功能延长改善
WO2008121882A1 (en) *	2007-03-29	2008-10-09	Novacardia, Inc.	Improved methods of administration of adenosine a1 receptor antagonists
US20090197900A1 (en) *	2007-03-29	2009-08-06	Howard Dittrich	Methods of treating heart failure and renal dysfunction in individuals with an adenosine a1 receptor antagonist
DE102011005232A1 (de)	2011-03-08	2012-09-13	AristoCon GmbH & Co. KG	Adenosin und seine Derivate zur Verwendung in der Schmerztherapie
TWI653227B (zh) *	2014-07-11	2019-03-11	Dow Agrosciences Llc	用於製備４－（１－（４－（全氟乙氧基）苯基）－１ｈ－１，２，４－三唑－３－基）苯甲醯疊氮化物之改良方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2460929A1 (de) *	1974-12-21	1976-06-24	Boehringer Sohn Ingelheim	Neue xanthinderivate, verfahren zu ihrer herstellung und ihre anwendung
US4364922A (en) *	1980-10-14	1982-12-21	University Of Virginia Alumni Patents Foundation	Adenosine antagonists in the treatment and diagnosis of A-V node conduction disturbances
DE3138397A1 (de) *	1981-09-26	1983-04-07	Hoechst Ag, 6230 Frankfurt	"arzneimittel, darin enthaltene vicinale dihydroxyalkylxanthine und herstellungsverfahren fuer diese xanthinverbindungen"
US4980379A (en) *	1988-06-30	1990-12-25	The University Of Virginia	Use of adenosine antagonists in the treatment of bradyarrhythmias and hemodynamic depression associated with cardiopulmonary resucitation and/or cardiovascular collapse
DE8817122U1 (de) *	1988-12-22	1993-02-04	Boehringer Ingelheim Kg, 55218 Ingelheim	Neue Xanthinderivate mit Adenosinantogenistischer Wirkung
JPH06102662B2 (ja) *	1989-09-01	1994-12-14	協和醗酵工業株式会社	キサンチン誘導体
DE4019892A1 (de) *	1990-06-22	1992-01-02	Boehringer Ingelheim Kg	Neue xanthinderivate
DE4205306B4 (de) *	1992-02-21	2005-11-24	Glüsenkamp, Karl-Heinz, Dr.	Säureamide, Arzneimittel mit denselben und Verfahren zur Herstellung von Säureamiden
US5288721A (en) *	1992-09-22	1994-02-22	Cell Therapeutics, Inc.	Substituted epoxyalkyl xanthines
WO1994016702A1 (fr) *	1993-01-26	1994-08-04	Kyowa Hakko Kogyo Co., Ltd.	Medicament contre l'elimination irreguliere des matieres fecales
US5736528A (en) *	1993-10-28	1998-04-07	University Of Florida Research Foundation, Inc.	N6 -(epoxynorborn-2-yl) adenosines as A1 adenosine receptor agonists
US5446046A (en) *	1993-10-28	1995-08-29	University Of Florida Research Foundation	A1 adenosine receptor agonists and antagonists as diuretics

1995
- 1995-12-29 US US08/581,655 patent/US5736528A/en not_active Expired - Lifetime
1996
- 1996-12-26 ES ES96945316T patent/ES2190487T3/es not_active Expired - Lifetime
- 1996-12-26 BR BR9612324-9A patent/BR9612324A/pt not_active IP Right Cessation
- 1996-12-26 DE DE69626705T patent/DE69626705T2/de not_active Expired - Lifetime
- 1996-12-26 PT PT96945316T patent/PT1019426E/pt unknown
- 1996-12-26 DK DK96945316T patent/DK1019426T3/da active
- 1996-12-26 NZ NZ326608A patent/NZ326608A/xx not_active IP Right Cessation
- 1996-12-26 WO PCT/US1996/020840 patent/WO1997024363A1/en not_active Ceased
- 1996-12-26 CN CNB961993383A patent/CN1163502C/zh not_active Expired - Fee Related
- 1996-12-26 JP JP9524592A patent/JP2000502712A/ja not_active Ceased
- 1996-12-26 CA CA002238736A patent/CA2238736C/en not_active Expired - Fee Related
- 1996-12-26 EP EP96945316A patent/EP1019426B1/en not_active Expired - Lifetime
- 1996-12-26 AT AT96945316T patent/ATE234322T1/de active
- 1996-12-26 KR KR1019980705044A patent/KR19990076916A/ko not_active Ceased
- 1996-12-26 AU AU15220/97A patent/AU728439B2/en not_active Ceased
1998
- 1998-04-06 US US09/056,195 patent/US5998387A/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
NZ326608A (en)	2000-04-28
PT1019426E (pt)	2003-07-31
AU1522097A (en)	1997-07-28
ES2190487T3 (es)	2003-08-01
US5736528A (en)	1998-04-07
CN1206420A (zh)	1999-01-27
EP1019426A1 (en)	2000-07-19
CN1163502C (zh)	2004-08-25
CA2238736C (en)	2003-09-16
DE69626705T2 (de)	2003-09-18
DE69626705D1 (de)	2003-04-17
ATE234322T1 (de)	2003-03-15
CA2238736A1 (en)	1997-07-10
BR9612324A (pt)	1999-12-28
JP2000502712A (ja)	2000-03-07
WO1997024363A1 (en)	1997-07-10
AU728439B2 (en)	2001-01-11
KR19990076916A (ko)	1999-10-25
US5998387A (en)	1999-12-07
EP1019426B1 (en)	2003-03-12

Publication	Publication Date	Title
DK0725782T3 (da)	2000-06-13	A1-adenosin-receptor-agonister og antiagonister
DK1019426T3 (da)	2003-07-14	Hidtil ukendte A1-adenosinreceptoragonister og -antagonister
BG101806A (bg)	1998-04-30	Индолови производни като антагонисти на 5-нт рецептори
WO1999064401A3 (en)	2003-04-17	Imidazolyl derivatives and their use as somatostatin receptor ligands
DE69719816D1 (de)	2003-04-17	N6-heterocyclisch substituierte Adenosin-Derivate
EA200101203A1 (ru)	2002-06-27	Производные пурина
PE20001225A1 (es)	2000-11-07	Derivados de adenina
DE69532162D1 (de)	2003-12-24	Cannabinoid-rezeptor-antagonisten
DK0760811T3 (da)	2010-01-25	Imidazolderivater som histaminreceptor H3-modulatorer
DE69428536D1 (de)	2001-11-08	A3 -adenosin -rezeptor agonisten
ES2175079T3 (es)	2002-11-16	Derivados de indol utiles como inhibidores de cgmp-pde.
BR1100460A (pt)	2000-07-18	Uso de derivados de tetrahidrocarbazole como receptores agonistas 5-ht1
EA200101177A1 (ru)	2002-04-25	Производные индола в качестве антагонистов прогестерона
BR0007864A (pt)	2001-11-06	Composto, e, uso de um composto
NO994850L (no)	1999-10-05	Farmakologiske midler
BR0015540A (pt)	2002-07-23	Antagonistas do receptor de adenosina e métodos de preparação e uso dos mesmos
AU5614198A (en)	1998-07-15	Isoquinolinamine and phthalazinamine derivatives which interact with crf receptors
NO963331L (no)	1996-10-09	5-Heteroarylindol-derivater som benzodiazepin-reseptorsete-agonister og antagonister
IL79264A0 (en)	1986-09-30	Tryptamine derivatives,pharmaceutical compositions containing them and their use in an assay for melatonin receptors
ES2169131T3 (es)	2002-07-01	Derivados de aril y heteroaril alcoxinaftaleno.
ES2187783T3 (es)	2003-06-16	Derivados de indolina utiles como antagonistas del receptor 5-ht-2c.
ATE217619T1 (de)	2002-06-15	Endothelin-rezeptor-antagonisten
IT8719009A0 (it)	1987-01-07	Composti antagonisti di recettori -h2 e procedimento per la loro preparazione.
DE69004827D1 (de)	1994-01-13	Alpha-adrenergene Rezeptor-Antagonisten.
IT1295356B1 (it)	1999-05-12	Derivati chinolinici, procedimento per la loro preparazione e uso come antagonisti del recettore nk3